CA2728915A1 - Benzyloxy anilide derivatives useful as potassium channel modulators - Google Patents

Benzyloxy anilide derivatives useful as potassium channel modulators Download PDF

Info

Publication number
CA2728915A1
CA2728915A1 CA2728915A CA2728915A CA2728915A1 CA 2728915 A1 CA2728915 A1 CA 2728915A1 CA 2728915 A CA2728915 A CA 2728915A CA 2728915 A CA2728915 A CA 2728915A CA 2728915 A1 CA2728915 A1 CA 2728915A1
Authority
CA
Canada
Prior art keywords
alkyl
cycloalkyl
formula
chr6
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2728915A
Other languages
English (en)
French (fr)
Inventor
Jim Zhen Wu
Jean-Michel Vernier
Huanming Chen
Jianlan Song
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch Health Americas Inc
Original Assignee
Valeant Pharmaceuticals International Inc USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valeant Pharmaceuticals International Inc USA filed Critical Valeant Pharmaceuticals International Inc USA
Publication of CA2728915A1 publication Critical patent/CA2728915A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/26—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA2728915A 2008-06-24 2009-06-24 Benzyloxy anilide derivatives useful as potassium channel modulators Abandoned CA2728915A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7530708P 2008-06-24 2008-06-24
US61/075,307 2008-06-24
PCT/US2009/048504 WO2010008894A1 (en) 2008-06-24 2009-06-24 Benzyloxy anilide derivatives useful as potassium channel modulators

Publications (1)

Publication Number Publication Date
CA2728915A1 true CA2728915A1 (en) 2010-01-21

Family

ID=41448228

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2728915A Abandoned CA2728915A1 (en) 2008-06-24 2009-06-24 Benzyloxy anilide derivatives useful as potassium channel modulators

Country Status (7)

Country Link
US (2) US8188314B2 (https=)
EP (1) EP2310369A4 (https=)
JP (1) JP2011525538A (https=)
AU (1) AU2009271302A1 (https=)
CA (1) CA2728915A1 (https=)
MX (1) MX2010014461A (https=)
WO (1) WO2010008894A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104470893A (zh) * 2012-04-30 2015-03-25 赛弗卢尔生命科学有限责任公司 氟化2-氨基-4-(苄基氨基)苯基氨基甲酸酯衍生物
CN103508943B (zh) * 2012-06-29 2017-06-09 江苏先声药业有限公司 作为钾通道调节剂的化合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533409B2 (https=) * 1972-04-15 1980-08-30
US3995041A (en) * 1975-10-30 1976-11-30 Miles Laboratories, Inc. Derivatives of 2-substituted-hydroxyanilino-hexahydro-2H-benzo[α]quinolizines
JPS5953917B2 (ja) * 1976-07-23 1984-12-27 武田薬品工業株式会社 テトラヒドロイソフタルイミド誘導体およびその製造方法
US4180509A (en) * 1977-07-01 1979-12-25 Merrell Toraude Et Compagnie α-Ethynyl tryptophanes
JPS6072787A (ja) * 1983-09-30 1985-04-24 Hodogaya Chem Co Ltd 感熱記録材料
FR2675504B1 (fr) * 1991-04-16 1995-01-27 Delalande Sa Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique.
IS4208A (is) * 1993-09-22 1995-03-23 Glaxo Group Limited 3-(tetrazólýl-benzyl)amínó-piperadidín afleiður
US6310211B1 (en) * 1996-09-10 2001-10-30 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
JP2002501502A (ja) * 1997-04-25 2002-01-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害物質
JP4721386B2 (ja) * 2001-07-10 2011-07-13 第一三共株式会社 新規ガランタミン類縁体
EP1511718B1 (en) * 2002-05-29 2009-05-06 F. Hoffmann-La Roche Ag N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
US7718692B2 (en) * 2004-02-13 2010-05-18 Carson John R Hetero-substituted acetanilide derivatives as analgesic agents
EP1603858A2 (en) * 2003-03-11 2005-12-14 NeuroSearch A/S Kcnq channel modulating compounds and their pharmaceutical use
AR043507A1 (es) * 2003-03-14 2005-08-03 Lundbeck & Co As H Derivados de anilina sustituidos y composiciones farmaceuticas
MXPA06003949A (es) * 2003-10-07 2006-06-27 Renovis Inc Compuestos amida como ligandos del canal de ion y su uso.
EP1684762A4 (en) * 2003-11-13 2009-06-17 Ambit Biosciences Corp UREA DERIVATIVES AS MODULATORS OF KINASE
WO2006022442A1 (ja) * 2004-08-24 2006-03-02 Santen Pharmaceutical Co., Ltd. ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
JP2009256208A (ja) * 2006-08-17 2009-11-05 Dainippon Sumitomo Pharma Co Ltd フタリド誘導体またはその薬学的に許容される塩
SG174095A1 (en) * 2006-08-23 2011-09-29 Valeant Pharmaceuticals Int Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators

Also Published As

Publication number Publication date
AU2009271302A1 (en) 2010-01-21
US20090326059A1 (en) 2009-12-31
MX2010014461A (es) 2011-04-28
JP2011525538A (ja) 2011-09-22
EP2310369A4 (en) 2014-02-19
US20120329869A1 (en) 2012-12-27
EP2310369A1 (en) 2011-04-20
WO2010008894A1 (en) 2010-01-21
US8492588B2 (en) 2013-07-23
US8188314B2 (en) 2012-05-29

Similar Documents

Publication Publication Date Title
US8293911B2 (en) Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
US8993593B2 (en) N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
JP2010501568A5 (https=)
ES2324214T3 (es) Derivados de n-acilaminobenceno como inhibidores de la monoamina oxidasa b selectiva.
TWI271396B (en) Hydroxy tetrahydro-naphthalenylurea derivatives
EP3917907A1 (en) Modulators of potassium ion channels and uses thereof
US8492588B2 (en) Benzyloxy anilide derivatives useful as potassium channel modulators
US20080188561A1 (en) N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
US20060167087A1 (en) Substituted aniline derivatives
AU2013211531A1 (en) Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
JP2008504312A (ja) フェニルカルボン酸誘導体および糖尿病の処置のためのその使用

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20150625